Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 MPro protein - an in silico and cell-based approach
Scientific Reports · 2025
DOI: 10.1038/s41598-025-05907-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2025. Verfasst von Khushboo Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nutrilite, Amway Corporation, Buena Park, CA, 90621, USA. khushboo.singh@amway.com. Hauptthemen laut MEDLINE: Phytochemicals, SARS-CoV-2, Coronavirus 3C Proteases, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The main protease (MPro) of SARS-CoV-2 plays a crucial role in viral replication and is a prime target for therapeutic interventions. Phytochemicals, known for their antiviral properties, have been previously identified as potential MPro inhibitors in several in silico studies. However, the efficacy of these remains in question owing to the inherent flexibility of the MPro binding site, posing challenges in selecting suitable protein structures for virtual screening. In this study, we conducted an extensive analysis of the MPro binding pocket, utilizing molecular dynamics (MD) simulations to explore its conformational diversity. Based on pocket volume and shape-based clustering, five representative protein conformations were selected for virtual screening. Virtual screening of a library of ~ 48,000 phytochemicals suggested 39 phytochemicals as potential MPro inhibitors. Based on subsequent MM-GBSA binding energy calculations and ADMET property predictions, five compounds were advanced to cell-based viral replication inhibition assays, with three compounds (demethoxycurcumin, shikonin, and withaferin A) exhibiting significant (EC50 < 10 uM) inhibition of SARS-CoV-2 replication. Our study provides an understanding of the binding interactions between these phytochemicals and MPro, contributing significantly to the identification of promising MPro inhibitors. Furthermore, beyond its impact on therapeutic development against SARS-CoV-2, this research highlights a crucial role of proper nutrition in the fight against viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nutrilite, Amway Corporation, Buena Park, CA, 90621, USA. khushboo.singh@amway.com.
- Department of Virology, Immunology, Microbiology, National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, 02118, USA.
- Department of Biochemistry and Molecular Biology, University of Texas Medical Branch at Galveston, Galveston, TX, 77555, USA.
- Amway Corporation, Ada, MI, 49301, USA.
Zitieren
APA
Singh, K., Patten, J. J., Dimet-Wiley, A., Davey, R. A., Watowich, S. J., Chandra, A., & Leverett, J. (2025). Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 MPro protein - an in silico and cell-based approach. Scientific Reports. https://doi.org/10.1038/s41598-025-05907-z
Vancouver
Singh K, Patten JJ, Dimet-Wiley A, Davey RA, Watowich SJ, Chandra A, et al. Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 MPro protein - an in silico and cell-based approach. Scientific Reports. 2025. doi:10.1038/s41598-025-05907-z
BibTeX
@article{Singh2025,
author = {Singh, Khushboo and Patten, J J and Dimet-Wiley, Andrea and Davey, Robert A and Watowich, Stanley J and Chandra, Amit and Leverett, Jesse},
title = {Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 MPro protein - an in silico and cell-based approach},
journal = {Scientific Reports},
year = {2025},
doi = {10.1038/s41598-025-05907-z}
}
EUVIMED